Sunali Wadehra

Recent research has identified neuronal autoantibodies as possible biomarkers for predicting treatment response in schizophrenia.

The NAVIGATE program shows great promise toward optimizing pharmacologic management of psychosis.

Deficits in social cognitive processing domains may be associated with functional impairments in bipolar disorder.

Investigators recommend tailoring exercise interventions to improve physical activity in patients with schizophrenia.

Investigators assessed olfactory identification differences in schizophrenia related to cognitive and social functioning in childhood and present state.

Investigators examined the risks and benefits of tDCS in patients with bipolar disorder.

Carefully assessing cognitive performance using a screening test to detect visuospatial/executive, attention, and memory dysfunction in patients with migraine.

Awareness of ASD and its manifestations and comorbidities remain imperative in the treatment of T1D, as both conditions require long-term medical follow-up to continue improving diabetes care and metabolic control outcomes.